Analysis of recovery trajectories in degenerative cervical myelopathy to facilitate improved patient counseling and individualized treatment recommendations

Blessing N. R. JajaNeuroscience Research Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto;

Search for other papers by Blessing N. R. Jaja in
jns
Google Scholar
PubMed
Close
 MD, PhD
,
Christopher D. WitiwNeuroscience Research Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto;
Department of Surgery, Division of Neurosurgery, University of Toronto;

Search for other papers by Christopher D. Witiw in
jns
Google Scholar
PubMed
Close
 MD, MS
,
Erin M. HarringtonTrauma and Neurosurgery Research Program, St. Michael’s Hospital, Toronto; and

Search for other papers by Erin M. Harrington in
jns
Google Scholar
PubMed
Close
 BMSc
,
Yingshi HeTrauma and Neurosurgery Research Program, St. Michael’s Hospital, Toronto; and

Search for other papers by Yingshi He in
jns
Google Scholar
PubMed
Close
 MS
,
Ali MoghaddamjouDepartment of Surgery, Division of Neurosurgery, University of Toronto;

Search for other papers by Ali Moghaddamjou in
jns
Google Scholar
PubMed
Close
 MD
,
Michael G. FehlingsNeuroscience Research Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto;
Division of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

Search for other papers by Michael G. Fehlings in
jns
Google Scholar
PubMed
Close
 MD, PhD
, and
Jefferson R. WilsonNeuroscience Research Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto;
Department of Surgery, Division of Neurosurgery, University of Toronto;

Search for other papers by Jefferson R. Wilson in
jns
Google Scholar
PubMed
Close
 MD, PhD
View More View Less
Restricted access

Purchase Now

USD  $45.00

Spine - 1 year subscription bundle (Individuals Only)

USD  $384.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $384.00
USD  $624.00
Print or Print + Online Sign in

OBJECTIVE

There is a need to better understand and predict postsurgical outcomes for degenerative cervical myelopathy (DCM) patients, particularly to support treatment decisions for patients with mild DCM. The goal of this study was to identify and predict outcome trajectories for DCM patients up to 2 years postsurgery.

METHODS

The authors analyzed two North American multicenter prospective DCM studies (n = 757). Functional recovery and physical health component quality of life were assessed in DCM patients at baseline, 6 months, and 1 and 2 years postoperatively using the modified Japanese Orthopaedic Association (mJOA) score and Physical Component Summary (PCS) of the SF-36, respectively. Group-based trajectory modeling was used to identify recovery trajectories for mild, moderate, and severe DCM. Prediction models for recovery trajectories were developed and validated in bootstrap resamples.

RESULTS

Two recovery trajectories were identified for the functional and physical components of quality of life: good recovery and marginal recovery. Depending on outcome and myelopathy severity, one-half to three-fourths of the study patients followed the good recovery trajectory characterized by improvement in mJOA and PCS scores over time. The remaining one-half to one-fourth of patients followed the marginal recovery trajectory, experiencing little improvement and, in certain cases, worsening postoperatively. The prediction model for mild DCM had an area under the curve of 0.72 (95% CI 0.65–0.80), with preoperative neck pain, smoking, and posterior surgical approach noted as dominant predictors of marginal recovery.

CONCLUSIONS

Surgically treated DCM patients follow distinct recovery trajectories in the first 2 years postoperatively. While most patients experience substantial improvement, a significant minority experience little improvement or worsening. The ability to predict DCM patient recovery trajectories in the preoperative setting facilitates the formulation of individualized treatment recommendations for patients with mild symptoms.

ABBREVIATIONS

CITL = calibration in the large; DCM = degenerative cervical myelopathy; GBTM = group-based trajectory modeling; LASSO = Least Absolute Shrinkage and Selection Operator; MCID = minimal clinically important difference; mJOA = modified Japanese Orthopaedic Association; PCS = Physical Component Summary; SMD = standardized mean difference.

Supplementary Materials

    • Supplemental Tables 1-4 (PDF 448 KB)
  • Collapse
  • Expand
  • 1

    Kalsi-Ryan S, Karadimas SK, Fehlings MG. Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder. Neuroscientist. 2013;19(4):409421.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Badhiwala JH, Ahuja CS, Akbar MA, et al. Degenerative cervical myelopathy—update and future directions. Nat Rev Neurol. 2020;16(2):108124.

  • 3

    Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis. Spine (Phila Pa 1976). 2015;40(12):E675E693.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Wilson JR, Tetreault LA, Kim J, et al. State of the art in degenerative cervical myelopathy: an update on current clinical evidence. Neurosurgery. 2017;80(3S):S33S45.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Fehlings MG, Tetreault LA, Riew KD, Middleton JW, Wang JC. A clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scope. Global Spine J. 2017;7(3 suppl):21S27S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Rhee J, Tetreault LA, Chapman JR, et al. Nonoperative versus operative management for the treatment degenerative cervical myelopathy: an updated systematic review. Global Spine J. 2017;7(3 suppl):35S41S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Fehlings MG, Tetreault LA, Riew KD, et al. A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression. Global Spine J. 2017;7(3 suppl):70S83S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Fehlings MG, Ibrahim A, Tetreault L, et al. A global perspective on the outcomes of surgical decompression in patients with cervical spondylotic myelopathy: results from the prospective multicenter AOSpine international study on 479 patients. Spine (Phila Pa 1976). 2015;40(17):13221328.

    • Search Google Scholar
    • Export Citation
  • 9

    Fehlings MG, Wilson JR, Kopjar B, et al. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am. 2013;95(18):16511658.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Tetreault LA, Kopjar B, Vaccaro A, et al. A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study. J Bone Joint Surg Am. 2013;95(18):16591666.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Tetreault LA, Côté P, Kopjar B, Arnold P, Fehlings MG. A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients. Spine J. 2015;15(3):388397.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Evaniew N, Charest-Morin R, Jacobs WB, et al. Cervical sagittal alignment in patients with cervical spondylotic myelopathy: an observational study from the Canadian Spine Outcomes and Research Network. Spine (Phila Pa 1976). 2022;47(5):E177E186.

    • Search Google Scholar
    • Export Citation
  • 13

    Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109138.

  • 14

    Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 2nd ed. Springer Nature; 2019.

    • Search Google Scholar
    • Export Citation
  • 15

    Karim SM, Cadotte DW, Wilson JR, et al. Effectiveness of surgical decompression in patients with degenerative cervical myelopathy: results of the Canadian prospective multicenter study. Neurosurgery. 2021;89(5):844851.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Evaniew N, Cadotte DW, Dea N, et al. Clinical predictors of achieving the minimal clinically important difference after surgery for cervical spondylotic myelopathy: an external validation study from the Canadian Spine Outcomes and Research Network. J Neurosurg Spine. 2020;33(2):129137.

    • Search Google Scholar
    • Export Citation
  • 17

    Tetreault L, Wilson JR, Kotter MR, et al. Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy. Neurosurg Focus. 2016;40(6):E14.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Tetreault LA, Zhu MP, Howard RM, et al. The discrepancy between functional outcome and self-reported health status after surgery for degenerative cervical myelopathy. Spine J. 2019;19(11):18091815.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Badhiwala JH, Hachem LD, Merali Z, et al. Predicting outcomes after surgical decompression for mild degenerative cervical myelopathy: moving beyond the mJOA to identify surgical candidates. Neurosurgery. 2020;86(4):565573.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Ghogawala Z, Terrin N, Dunbar MR, et al. Effect of ventral vs dorsal spinal surgery on patient-reported physical functioning in patients with cervical spondylotic myelopathy: a randomized clinical trial. JAMA. 2021;325(10):942951.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 203 203 203
Full Text Views 62 62 62
PDF Downloads 38 38 38
EPUB Downloads 0 0 0